Search results
Atrial fibrillation (also called AFib or AF) is the most common type of supraventricular arrhythmia with irregular beats that are too fast (tachycardia).
- Burgeoning Hybrid Atrial Fibrillation Program at THI Bolstered by FDA ...
HOUSTON, TX (April 30, 2021) – The Texas Heart Institute...
- Burgeoning Hybrid Atrial Fibrillation Program at THI Bolstered by FDA ...
The Texas Heart Institute Center for Cardiovascular Care doctors are leaders in treating patients with atrial fibrillation (AFib) and have advanced the most innovative AFib care treatments available to patients today. Make an Appointment (713) 790-9401
Atrial Fibrillation, or A Fib, is the most common type of cardiac arrhythmia, affecting approximately 2.2 million people in this country. It is typically diagnosed by electrocardiogram, Holter monitor, event recorders and sometimes trans-telephonic monitors.
Atrial fibrillation, called “AFib” for short, is one of the most severe heart rhythm disorders (arrhythmias). It causes rapid irregular heartbeats (tachycardia) where single muscle fibers in your heart contract out of sync with the others.
With atrial fibrillation, or AFib, an abnormal heartbeat (arrhythmia) occurs. The arrhythmia makes the heart’s two upper chambers (atria) contract irregularly and much faster than they should, usually more than 400 beats per minute.
In this video, Dr. Mitch Tan, a cardiac electrophysiology fellow at The Texas Heart Institute, explains atrial fibrillation (AFib), an abnormal heart rhythm associated with increased risks of stroke, hospitalization, and death.
HOUSTON, TX (April 30, 2021) – The Texas Heart Institute echoes the exciting FDA approval of innovative medical device company AtriCure’s EPi-Sense System for treating long-standing persistent atrial fibrillation (LSPAF) in heart patients.
